open access

Vol 5, Supp. A (2009)
suplement
Published online: 2009-04-29
Get Citation

Angiogenesis and antiangiogenic treatment in plazmocytoma

Anna Dmoszyńska

open access

Vol 5, Supp. A (2009)
suplement
Published online: 2009-04-29

Abstract

Angiogenesis plays a key role in carcinogenesis and it is a stabile pathomorphologic symptom of plasmocytoma. Consequently antiangogenic agents are succesfully introduced to plasmocytoma therapy as well as monoclonal antibodies.
Recently a great interest has been observed in antiangiogenic therapy. In clinical studies of various phase there are many molecules targeted on angiogenesis inhibition. Numerous facts indicate that antiangiogenic therapy will improve cancer treatment outcomes in future.

Abstract

Angiogenesis plays a key role in carcinogenesis and it is a stabile pathomorphologic symptom of plasmocytoma. Consequently antiangogenic agents are succesfully introduced to plasmocytoma therapy as well as monoclonal antibodies.
Recently a great interest has been observed in antiangiogenic therapy. In clinical studies of various phase there are many molecules targeted on angiogenesis inhibition. Numerous facts indicate that antiangiogenic therapy will improve cancer treatment outcomes in future.
Get Citation

Keywords

angiogenesis; plasmocytoma; antiangiogenic treatment

About this article
Title

Angiogenesis and antiangiogenic treatment in plazmocytoma

Journal

Oncology in Clinical Practice

Issue

Vol 5, Supp. A (2009)

Pages

56-61

Published online

2009-04-29

Keywords

angiogenesis
plasmocytoma
antiangiogenic treatment

Authors

Anna Dmoszyńska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl